Cancer research is moving faster than ever—but too many patients never feel the impact of that progress. Artificial Intelligence (AI) is emerging as one tool that could help change that.

In the Season 6 finale of Science Will Win, Dr. Raven Baxter follows the human journey behind AI in oncology—from the moment of diagnosis to the real‑world barriers that determine access to care.

Along the way, we explore how thoughtfully designed artificial intelligence is reshaping trial design, enrollment, eligibility, and access—helping patients regain agency and bridging the gap between scientific breakthroughs and real‑world cancer care.

As the season concludes, one thing is clear: progress matters most when it reaches the people who need it.

Featured guests:
– Dr. Lionel Kankeu Fonkoua, Medical Oncologist and Translational Researcher, Mayo Clinic
– Jeff Legos, Chief Oncology Officer, Pfizer
– Dr. Ravi Parikh, Medical Oncologist; Director, Human‑Algorithm Collaboration Lab
– Maya R. Said, Founder and CEO, Outcomes4Me

Dive into the episode here:
00:00 – Past episodes introduce us to an emerging tech advancement
04:16 – What is a clinical trial?
07:35 – AI accelerating the pace of oncology
12:42 – Clinical trials and AI: How can it help?
16:17 – A gap between innovation and patient access
19:16 – Maya's story
23:47 – Clinical trials for AI tools
27:54 – Conclusion: building pathways alongside scientific innovation

Check out our YouTube channel (@Pfizer) to watch full interviews between Raven & some of the patients featured.

Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.

*The content in this episode is for informational purposes only and does not provide medical advice. Pfizer does not endorse or sponsor third‑party tools referenced. Patients should not use the tools described as a replacement for discussions with a healthcare provider. Patients should consult their healthcare provider regarding medical decisions.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What comes after a cancer diagnosis and treatment?

In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most important, and often overlooked, chapters for cancer patients: survivorship. As five-year survival rates climb to 70%, more people than ever are living with and beyond cancer. But longer survival brings its own complex challenges, and our care systems are still catching up.

You'll hear from experts and advocates working at the intersection of medicine, policy, and community. We’ll discuss what it really takes to support people through this transition — when the clinical benchmarks have passed and it’s time to go back to “normal life”.

From patient care plans and workplace disclosure to mental health, this episode makes one thing clear: survivorship demands dignity, support, and a whole new kind of care.

Featured guests:
– Tina Deignan, Commercial President, Pfizer Oncology
– Shelley Fuld Nasso, CEO, Cancer Nation
– Rebecca Nellis, Executive Director, Cancer and Careers
– Bob Riter, Breast Cancer Patient & Advocate

Dive into the episode here:
00:00 – The ongoing battle with cancer
03:43 – Rethinking survivorship
05:32 – The five-year survival myth
07:00 – The history of the term "survivor"
09:36 – Bob’s journey with breast cancer
11:38 – Lost in transition and survivorship care plans
14:25 – The intersection of cancer and work
18:49 – Rethinking how work gets done
20:00 – Disclosure and improving company culture
20:59 – The swivel technique
23:19 – Controlling your narrative
25:11 – Standardizing long-term survivorship care through policy
27:08 – Lack of access to care leads to disparities in survival rates
29:48 – Bob's second journey with cancer
32:21 – Takeaways and peek into our final episode

Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Bob Riter on his cancer journey.

Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What women carry through cancer is more than a diagnosis.

In our third episode of this miniseries, Dr. Raven Baxter explores how generations of women turned silence into advocacy and fear into progress, reshaping the perceptions and discussions around cancer over time. Through history, science, and a powerful story from Katrina M. Johnson — a woman who has lived through multiple breast cancer diagnoses and now advocates for others — the episode highlights how women continue to drive change in how cancer is understood, treated, and lived with.

Featured guests:
– Dr. Isaac Chan, Physician‑scientist and Assistant Professor, Department of Internal Medicine, University of Texas Southwestern
– Kirsten Gardner, Director of Medical Humanities, University of Texas at San Antonio; Author
– Katrina M. Johnson, Breast Cancer Patient; Director of Advocacy and Professional Relations, Pfizer Oncology

Dive into the episode here:
00:00 – The start of three cancer diagnoses
02:06 – The history of breast cancer awareness campaigns
09:27 – How the mastectomy has changed
12:59 – Evolving research in breast cancer
15:10 – Breast cancer impacting body image and sexuality
19:29 – Emerging therapies to address breast cancer
21:18 – Addressing the BRCA gene today
23:30 – Breast cancer advocacy then and now
26:08 – Katrina's takeaways about her breast cancer story

Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Katrina M. Johnson on her breast cancer journey.

Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.